Mariner’s Pulmonx LUNG Stock Holding History

Mariner’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.1K	Buy	38,530 +27,463	+248%	+$37.8K	﹤0.01%	3413
2026 Q1	$14.3K	Buy	+11,067	New	+$18.3K	﹤0.01%	3513

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Mariner's LUNG Position: Q2 2026 in Review

Mariner increased its Pulmonx (LUNG) stake by 248% in Q2 2026, buying an estimated $37.8K and bringing the position to 38,530 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3413.

Mariner first reported a position in LUNG in Q1 2026 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Mariner held 38,530 shares of Pulmonx worth $50.1K as of Q2 2026.
Mariner bought 27,463 Pulmonx shares in Q2 2026, an estimated $37.8K.
Pulmonx made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3413 holding.
Mariner first reported a position in Pulmonx in Q1 2026 and has held it in 2 quarters since.
108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.